A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Solid Tumor|Breast Cancer|Pancreatic Cancer|Ovarian Cancer|Colorectal Cancer
Interventions: DRUG: SON-DP
Sponsor: Qurgen Inc.